Truist Securities Initiates Coverage On Cormedix with Buy Rating, Announces Price Target of $20
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.
Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.
Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.
Start your FREE 14-day trial of Benzinga Pro today.
View More Analyst Ratings for CRMD
Latest Ratings for CRMD
Date Firm Action From To Sep 2020 JMP Securities Initiates Coverage On Market Outperform Sep 2020 Truist Securities Initiates Coverage On Buy Aug 2020 HC Wainwright & Co. Maintains Buy
View the Latest Analyst Ratings
Posted-In: News Price Target Initiation Analyst Ratings